Articles Archives - Page 83 of 624

TuesdayMar 14, 2023 11:15 am

DGE’s 3rd Risk Based Quality Management Summit to Integrate Quality into Clinical Trials and Ensure Effective Monitoring

Clinical research executives, data management specialists, and industry experts, are all invited to attend the 3rd Risk Based Quality Management Summit that will be held from April 25-26, 2023 at the Le Méridien, in Philadelphia. The summit will be focused on conferring the details of executing data flow process maps, data monitoring tools, audit trails, and quality tolerance limits. RBQM is now being embraced to address the significant increase in research duration, cost, and complexity of clinical research. The newest version of the Good Clinical Practice (“GCP”) quality standard extends the RBM approach to every facet of study execution, implementing…

TuesdayMar 14, 2023 9:45 am

SideChannel Inc. (SDCH), Virgin Voyages Extend Engagement, Adding Virtual Chief Privacy Officer Services to Help Safeguard Data and Information

SideChannel is committed to creating robust and top-tier cybersecurity programs for small and mid-market businesses (“SMBs”), thus helping them protect vital information and customers One of the companies SideChannel has helped achieve this goal is Virgin Voyages, which has expanded its engagement with SideChannel to improve its data privacy efforts with the addition of a virtual chief privacy officer (“vCPO”) from SideChannel The move builds on an earlier engagement, bolstering Virgin Voyages’ goal to protect the important information relating to its crew, sailors, and partners A recent study by IBM Corp. (NYSE: IBM) revealed that the average cost of a…

TuesdayMar 14, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Encouraged by Positive Findings from its DIAB-A22-1 Animal Model Study on Potential DehydraTECH-CBD(TM) Treatment for Diabetes

Lexaria’s DIAB-A22-1 animal model study just concluded, highlighting three positive outcomes, including an improvement in general activity, significant reductions in body weight, and improved triglyceride and cholesterol levels The study was undertaken by a third-party testing laboratory in Canada involving 24 obese and eight lean rats for a total of 32 male Zucker rats The success of this DIAB-A22-1 study marks a significant milestone for Lexaria, even as it continues to explore its patented DehydraTECH(TM) technology application in various other areas, including nicotine replacement, epilepsy, hypertension, dementia and more With its unique product offering, a growing list of patents, and…

MondayMar 13, 2023 10:30 am

Silo Pharma Inc. (NASDAQ: SILO) Set to Benefit as Study Supports the Efficacy of Psychedelics in Treating ‘Drug-Resistant’ Depression

A recent medical study found that psychedelic drugs showed promise as a treatment alternative for hard-to-treat depression Psychedelics were found to activate a greater number of serotonin 2A receptors then traditional antidepressant drugs, largely because of their ability to penetrated through cells’ fatty outer membranes The study reinforces the potential use of psychedelic drugs, and psilocybin in particular, as a treatment methodology for a variety of mental health related conditions Silo Pharma, a developmental stage biopharmaceutical company has long focused around merging traditional therapeutics with psychedelic research In a study carried out between 2013 to 2016, researchers found that 8.1%…

MondayMar 13, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leverages Top-Tier Leadership and GMP Facility to Advance Rapid Development of New Therapeutic and Prophylactic Technologies for Multiple Diseases and Disorders

BiondVax is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, primarily for the treatment of infectious and autoimmune diseases The company is led by CEO Amir Reichman, with over 20 years of international experience as a biopharma expert Amir took company reins in 2021 and pivoted the mission and vision including diversifying risks With new focus and opportunity, BiondVax now developing an innovative alpaca-derived nanosized antibody (“NanoAb”) pipeline BiondVax is aggressively advancing new NanoAb therapeutic and prophylactic technologies owing to exclusive collaborations, previous pharma development experience and a state-of-the-art GMP manufacturing facility Leveraging top-tier pharmaceutical industry…

MondayMar 13, 2023 9:00 am

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) subsidiary McEwen Copper adds $30 Million Boost from Nuton LLC to recent Stellantis investment of $155 Million, Plans for subsidiary IPO

McEwen Mining subsidiary McEwen Copper has been gaining increased financial support as it develops a major copper mine opportunity in Argentina described as one of the 10 largest undeveloped deposits in the world Mining giant Rio Tinto’s venture Nuton LLC has boosted last year’s $25 million investment into McEwen Copper with a new $30 million addition, all on top of the recent Stellantis investment of approximately $155 million The project in Argentina’s San Juan province benefits from a mining-friendly government and population The demand for copper is expected to continue to grow as a result of its importance to green…

FridayMar 10, 2023 9:45 am

Cybersecurity vCISO Provider SideChannel Inc. (SDCH) Meets Investors, Addresses Company Operations, in Investor Day Webcast

Massachusetts-headquartered cybersecurity services and technology provider SideChannel Inc. is building its operational model on contracting out its employees’ expertise as “virtual” chief information security officers (vCISOs) to companies that can’t afford to staff their own CISOs SideChannel’s CEO and CFO recently addressed the company’s history, expertise and strategies for the future in an Investor Day webcast that is now being rebroadcast on the company’s YouTube channel The webcast noted that SideChannel is tapping into an underserved market of mid-market clients whose needs for cybersecurity mirror those of larger-budget companies who can afford to employ their own CISOs During 2022, about…

FridayMar 10, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Additional Findings From Human Clinical Study, Demonstrating DehydraTECH(TM)-CBD Effects on Hypertension

The global antihypertensive drugs market was valued at around $20.5 billion in 2021 and is expected to reach $39.5 billion by 2030, growing at a CAGR of 2.95% Lexaria’s patented DehydraTECH(TM) technology is designed to formulate and deliver lipophilic drugs and active pharmaceutical ingredients (“APIs”), increasing effectiveness and improving how drugs are delivered into the bloodstream DehydraTECH is suitable for use with a wide range of product formats, including pharmaceuticals, nutraceuticals, and over-the-counter capsules, pills, tablets, or oral suspensions Lexaria is continuing to evaluate the results of its HYPER-H21-4 human clinical study and will report additional findings as they become…

ThursdayMar 09, 2023 10:30 am

Exploring the Advancements in Blockchain Technology at the 9th Annual Blockchain Africa Conference 2023

The 9th annual Blockchain Africa Conference 2023 is a highly anticipated event for those in the tech and finance industries. This year's conference will take place on March 16 – 17 in Johannesburg, South Africa and will bring together experts from all over the world to discuss the latest trends and developments in blockchain technology. Blockchain technology is one of the most exciting innovations of recent times and has the potential to revolutionize the way we conduct financial transactions, store and secure data, and manage digital identities. The Blockchain Africa Conference 2023 is a perfect opportunity to learn about these…

ThursdayMar 09, 2023 9:45 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Pushes for a Net Zero Future with Carbon-Neutral RNG

RNG is a carbon-neutral alternative to natural gas that is compatible with existing pipeline infrastructure RNG is considered carbon-negative because it is produced from organic materials that otherwise decompose and generate methane emissions EverGen leads RNG adoption in Canada by acquiring, developing, and managing portfolio of RNG and waste-to-energy projects EVGIF aims to develop a cross-country RNG platform of 20+ facilities within five years, starting with British Columbia, Alberta, and Ontario EverGen management predicts RNG opportunity to exceed C$16 billion for RNG producers EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF) is focused on achieving a Net-Zero future by leveraging the power…

Site Search

Company Search

Category: Articles